M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.52 EUR -3.34% Market Closed
Market Cap: 104.5m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Maat Pharma SA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maat Pharma SA
Revenue Peer Comparison

Comparables:
VLA
G
GNFT
IVA
ALERS
OSE

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
M
Maat Pharma SA
PAR:MAAT
Revenue
€2.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Revenue
€221.6m
CAGR 3-Years
26%
CAGR 5-Years
15%
CAGR 10-Years
20%
G
Genfit SA
PAR:GNFT
Revenue
€84m
CAGR 3-Years
151%
CAGR 5-Years
61%
CAGR 10-Years
29%
Inventiva SA
PAR:IVA
Revenue
€15.6m
CAGR 3-Years
255%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Revenue
€144.2m
CAGR 3-Years
-13%
CAGR 5-Years
21%
CAGR 10-Years
17%
OSE Immunotherapeutics SA
PAR:OSE
Revenue
€83.4m
CAGR 3-Years
83%
CAGR 5-Years
33%
CAGR 10-Years
N/A

See Also

What is Maat Pharma SA's Revenue?
Revenue
2.2m EUR

Based on the financial report for Dec 31, 2023, Maat Pharma SA's Revenue amounts to 2.2m EUR.

What is Maat Pharma SA's Revenue growth rate?
Revenue CAGR 1Y
56%

Over the last year, the Revenue growth was 56%.

Back to Top